Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants

NCT02931357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Pain Teeth

Interventions

DEVICE: Hyaluronic Acid 0.54%
DRUG: Calgel®

Sponsor

Ricerfarma S.r.l

Collaborators

[object Object]
[object Object]